Overview
- 102 inspections across 101 sites are on record.
- 593 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-07-31.
At a glance
Inspections
102
Sites
101
Observations
593
Career since
Jul 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| UNIVERSITY OF CALIFORNIA, LOS ANGELES | 31 Jul 2020 | Human Drugs | On file |
| UCSF Radiopharmaceutical Facility | 24 Jul 2020 | Human Drugs | On file |
| Mylan Laboratories Limited | 28 Feb 2020 | Human Drugs | On file |
| Somerset Therapeutics Private Limited | 19 Feb 2020 | Human Drugs | On file |
| OraLabs, Incorporated | 10 Jan 2020 | Human Drugs | On file |
Sites inspected
UNIVERSITY OF CALIFORNIA, LOS ANGELESLos Angeles, United States1 insp.
UCSF Radiopharmaceutical FacilitySan Francisco, United States1 insp.
Mylan Laboratories LimitedBangalore, India1 insp.
Somerset Therapeutics Private LimitedBengaluru, India1 insp.
OraLabs, IncorporatedParker, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jeffrey P Raimondi6 shared
Zhongren Wu5 shared
Janet Pulver5 shared
Elisa J Beard5 shared
Anastasia M Shields4 shared
Alan P Kurtzberg3 shared
Daniel J Roberts3 shared
Liming Zhang3 shared
Scott N Lim2 shared
Steven M Weinman2 shared
Full investigator report
Get the verbatim findings behind Linda F Murphy's 593 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site